The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterationsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat Was Studied?
This cross-sectional case-control study investigated whether intestinal microbiota composition differs across the tuberculosis (TB) disease spectrum and how those differences might relate to the transition from latent infection to active disease. Fecal samples from individuals with active TB, latent TB infection (LTBI), and healthy controls were profiled by 16S rDNA amplicon sequencing, with comparisons of alpha and beta diversity, differential taxa (LEfSe), predicted metabolic pathways, and the diagnostic performance of candidate microbial markers. The authors framed the analysis around identifying microbiota-driven mechanisms that could plausibly favor reactivation and progression.
Who Was Studied?
The cohort was recruited in China and divided into three groups: patients with active tuberculosis, individuals with latent tuberculosis infection, and healthy controls without M. tuberculosis exposure. All microbiome characterization was performed on stool (fecal) samples. As with most gut microbiota studies in TB, recent or concurrent antibiotic and anti-tuberculosis exposure in the active disease group is an important consideration when interpreting between-group differences.
What Were the Key Findings?
Alpha diversity was lowest in active TB and highest in healthy controls, with the latent infection group falling in between, and beta diversity differed significantly across the three groups. Differential-abundance analysis showed that latent infection was enriched for beneficial, largely commensal taxa including Romboutsia, Bifidobacterium, and Lactobacillus, whereas active disease was enriched for pro-inflammatory organisms including Ruminococcus gnavus, Streptococcus, and Erysipelatoclostridium. Functional prediction indicated greater activity of the pentose phosphate pathway in active disease, and Romboutsia showed modest standalone diagnostic value for distinguishing TB (reported AUC of approximately 0.65, with low sensitivity and higher specificity).
What Are the Implications?
The data are consistent with a model in which progressive loss of diversity and depletion of beneficial taxa, alongside expansion of pro-inflammatory bacteria, accompany the shift from latent infection to active tuberculosis, potentially by dampening protective IFN-γ and IL-17 responses and thereby favoring M. tuberculosis survival and spread. These findings are associative and cannot establish causation or direction, and antibiotic and anti-tuberculosis drug exposure may confound the active-disease signature. Nonetheless, the results support further investigation of gut microbial markers such as Romboutsia as adjuncts for risk stratification and of microbiota modulation as a potential avenue to limit progression.